The April Journal Club will discuss the latest paper from the Salk Institute
Published in Nature Medicine, the findings demonstrate a novel CRISPR/Cas9 gene-editing treatment that can suppress accelerated aging in mice with Hutchinson Gilford progeria syndrome. This treatment offers important insights into the molecular mechanisms involved in accelerated ageing, and how to reduce toxic protein levels via gene therapy. Researchers hope to apply this therapy in humans, to possibly cure progeria and slow down the aging processes to delay age-related diseases.
Link to paper: https://www.nature.com/articles/s41591-019-0343-4
Abstract.
Source:
